MFDS
- Marketing authorisation holder: LILLY
- Status: likely_approved
🇰🇷 Kappadione in South Korea
Kappadione (MENADIOL SODIUM DIPHOSPHATE) regulatory status in South Korea.
Marketing authorisation
Kappadione in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in South Korea
Frequently asked questions
Is Kappadione approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Kappadione in South Korea?
LILLY holds the South Korean marketing authorisation.